Differentiation Therapy of Myelodysplastic Syndromes with Retinoic Acid

References

• Bennett J. M., Daniel D., Flandrin M. T., Gal-Ton G., Catovsky D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 89–99
   PubMed Web of Science ®Google Scholar
• Koeffler H. P. Myelodysplastic syndromes (preleukemia). Semin. Hematol. 1986; 23: 284–99
   PubMed Web of Science ®Google Scholar
• Cheson B. D. Chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Semin. Oncol. 1992; 19: 85–94
   PubMed Web of Science ®Google Scholar
• Ichikawa Y. Differentiation of a cell line of myeloid leukemia. J. Cell. Physiol. 1969; 74: 223–34
   PubMed Web of Science ®Google Scholar
• Sachs L. Control of normal cell differentiation and phenotype reversion of malignancy in myeloid leukemia. Nature 1978; 274: 535–39
   PubMed Web of Science ®Google Scholar
• Hozumi M. Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Adv. Cancer Res. 1983; 38: 210–69
   Google Scholar
• Kizaki M., Koeffler H. P. Differentiation-inducing agents in the treatment of myelodysplastic syndromes. Semin. Oncol. 1992; 19: 95–105
   PubMed Web of Science ®Google Scholar
• Bollag W. Retinoids and cancer. Cancer Chemother. Pharmacol. 1979; 33: 207–15
   Google Scholar
• Bollag W. Vitamin A and retinoic acids: From nutrition to pharmacotherapy in dermatology and oncology. Lancet 1983; 1: 860–63
   PubMed Web of Science ®Google Scholar
• Zelent A., Krust A., Petkovich M., Kastner P., Chambon P. Cloning of murine retinoic acid receptor alpha and beta cDNAs and of a novel third receptor gamma predominantly expressed in skin. Nature 1989; 339: 714–17
   PubMed Web of Science ®Google Scholar
• Mori S. The changes in the para-ocular glands which follows the administration of diets low in fat-soluble vitamin A: with notes of the effect of the same diets on salivary glands and the mucus of the larynx and trachea. Bull. John Hopkins Hosp. 1922; 33: 357
   Google Scholar
• Wolbach S. B., Howe P. R. Tissue changes following deprivation of fat soluble A vitamin. J. Exp. Med. 1925; 42: 753–77
   PubMedGoogle Scholar
• Fujimaki Y. Formation of gastric carcinoma in albino rats fed on deficient diets. J. Cancer Res. 1926; 10: 469–77
   Google Scholar
• Lasnitziki I. The influence of A vitaminosis on the effect of 20-methylcholanthrene on mouse prostate glands grown in vitro. Br. J. Cancer 1955; 9: 434–41
   PubMed Web of Science ®Google Scholar
• Bollag W. Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A (retinoic acid). Eur. J. Cancer 1972; 8: 689–93
   PubMed Web of Science ®Google Scholar
• Bollag W. Effect of vitamin A on transplantable and chemically induced tumors. Cancer Chemother. Rept. 1971; 55: 53–58
   PubMedGoogle Scholar
• Moon R. C., Grubbs C. J., Sporn M. B. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate. Cancer Res. 1976; 36: 2626–30
   PubMed Web of Science ®Google Scholar
• Lippman S. M., Kessler J. F., Meyskens F. L., Jr. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep. 1987; 71: 391–405
   PubMedGoogle Scholar
• Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem. Biophys. Acta 1980; 605: 33–91
   PubMed Web of Science ®Google Scholar
• Douer D., Koeffler H. P. Inhibition of the clonal growth of human myeloid leukemia cells. J. Clin. Invest. 1982; 69: 277–83
   PubMed Web of Science ®Google Scholar
• Marth C., Mayer I., Daxenbichler G. Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. Biochem. Pharmacol. 1984; 33: 2217–21
   PubMed Web of Science ®Google Scholar
• Traganos F., Higgins P. J., Bueti C. Effects of retinoic acid versus dimethylsulfoxide on Friend erythroleu-kemia cell growth: Part II. Induction of quiescent nonproli-ferating cells. J. Natl. Cancer Inst. 1984; 73: 205–18
   PubMed Web of Science ®Google Scholar
• Lotan R., Nicolson G. L. Inhibitory effects of retinoic acid or retinyl acetate on the growth of untrans-formed, transformed and tumor cells in vitro. J. Natl. Cancer Inst. 1977; 59: 1717–22
   PubMed Web of Science ®Google Scholar
• Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 393–403
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 1980; 77: 2936–40
   PubMed Web of Science ®Google Scholar
• Olsson I. L., Breitman T. R. Induction of differentiation of human histiocytic lymphoma cell line U939 by retinoic acid and cyclic adenosine 3′-5′-monophosphate-in-ducing agnets. Exp. Cell. Res. 1982; 138: 193–98
   PubMed Web of Science ®Google Scholar
• Sporn M. B., Roberts A. B. Role of retinoids in differentiation and carcinogenesis. J. Natl. Cancer Inst. 1984; 73: 1381–87
   PubMedGoogle Scholar
• Koeffler H., Amatruda T. The effect of retinoids on haematopoiesis—Clinical and laboratory studies. In Retinoids, Differentiation and Disease, J. Nugent, S. Clark. Chiba Foundation, London 1985; 252–73
   Google Scholar
• Smith M. A., Parkinson D. R., Cheson B. D., Friedman M. A. Retinoids in cancer therapy. J. Clin. Oncol. 1992; 10: 839–64
   PubMed Web of Science ®Google Scholar
• Gold E. J., Mertelmann R. H., Itri L. M., Gee T., Arlin Z., Kempin S., Clarkson B., Moore M. A. S. Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat. Rep. 1983; 67: 981–86
   PubMedGoogle Scholar
• Greenberg B. R., Durie B. D., Barnett T. C., Meyskens F. L., Jr. Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat. Rep. 1985; 69: 369–74
   PubMedGoogle Scholar
• Picozzi V. I., Jr., Swanson G. E., Morgan R., Hecht F., Greenberg P. L. 13-cis retinoic acid treatment for myelodysplastic syndromes. J Clin. Oncol. 1986; 4: 589–95
   PubMed Web of Science ®Google Scholar
• Clark R. E., Ismail S. A. D., Jacobs A., Payne H., Smith A. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndromes. Br. J. Haematol. 1987; 66: 77–83
   PubMed Web of Science ®Google Scholar
• Clark R. E., Jacobs A., Lush C. J., Smith S. A. Effect of 13-cis-retinotic acid on survival of patients with myelodysplastic syndromes. Lancet 1987; 1: 763–65
   PubMed Web of Science ®Google Scholar
• Leoni F., Ciolli S., Longo G., Messori A., Ferrini P. R. 13-cis-retinoic acid treatment in patients with myelodysplastic syndrome. Acta Haematol 1988; 80: 8–12
   PubMed Web of Science ®Google Scholar
• Koeffler H. P., Heitjan D., Mertelsman R., Kolitz J. E., Schulman P., Itri L., Gunter P., Besa E. Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders. Blood 1988; 71: 703–08
   PubMed Web of Science ®Google Scholar
• Besa E. C., Abrahm J. T., Bartholomew M. J., Hyzinski M., Nowell P. C. Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndromes and decreased toxicity with addition of alpha-to-copherol. Am. J. Med. 1990; 89: 739–47
   PubMed Web of Science ®Google Scholar
• Huang M., Ye Y., Chen S., Chai J., Lu J., Zhoa L., Gu L., Wang Z. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: Part I. Clinical results. Blood 1990; 76: 704–09
   Google Scholar
• Warrell R. P., Frankel S. R., Miller W. H., Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 1991; 324: 385–93
   Web of Science ®Google Scholar
• Chen Z.-X., Xue Y.-Q., Zhang R., Tao R. F., Xia X. M., Li C., Wang W., Zu W. Y., Yao X.-Z., Ling B.-L. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991; 78: 413–19
   Google Scholar
• Ohno R., Naoe T., Yoshida H. Acute promyelocytic leukemia and differentiation therapy. Naika 1992; 69: 359–62
   Google Scholar
• Chomienne C., Ballerini P., Balitrand N., Daniel M., Fenaux P., Castaigne S., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: Part II. In vitro studies: Structure-function relationship. Blood 1990; 76: 710–17
   Google Scholar
• Ohno R., Naoe T., Hirano M., Kobayashi M., Hirai H., Tsubaki K., Oh H., The Leukemia Study Group of the Ministry of Health and Welfare. Treatment of myelodysplastic syndromes with all-trans retinoic acid. Blood 1993; 81: 1152–54
   PubMed Web of Science ®Google Scholar
• Ohno R., Tatsumi N., Hirano M., Imai K., Mizoguchi H., Nakamura T., Kosaka M., Takatsuki K., Yamaya T., Toyama K., Yoshida T., Masaoka T., Hashimoto S., Ohshima T., Kimura I., Yamada K., Kimura K. Treatment of myelodysplastic syndromes with orally administered 1 -B-D-arabinofuranosylcytosine-5′-stearylphosphate. Oncology 1991; 48: 451–53
   PubMed Web of Science ®Google Scholar
• Fukutani H., Naoe T., Saito H., Ohshima T., Omine M., Miura Y., Mizoguchi H., Kimura I., Tomonaga M., Ohno R. Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phen-ylbutyryl-L-leucine (ubenimex). Jpn. J. Clin. Oncol. 1991; 21: 287–92
   PubMed Web of Science ®Google Scholar
• Visani G., Cenacchi A., Tosi P., Finelli C., Fogli M., Gamberi B., Martinelli G., Tura S. All-trans retinoic acid improves erythropoiesis in myelodysplastic syndromes: a case report. Br. J. Haematol 1992; 81: 444–46
   PubMed Web of Science ®Google Scholar
• Francis G. E., Guimaraes J. E. T.E., Bemey J. J., Wing M. A. Synergistic interaction between differentiation inducers and DNA synthesis inhibitors: A new approach to differentiation induction in myelodysplasia and acute myeloid leukemia. Leuk. Res. 1985; 9: 573–78
   PubMed Web of Science ®Google Scholar
• Chomienne C., Balitrand N., Degos L., Abita J. P. 1-B-D-Arabinofuranosyl cytosine and all-trans-retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemia cells. Leuk. Res. 1986; 10: 631–36
   PubMed Web of Science ®Google Scholar
• Ho A. D., Martin H., Knauf W., Reichardt P., Trumper L., Hunstein W. Combination of low-dose cytar-abine and 13-cis retinoic acid in the treatment of myelodys-plastic syndromes. Leuk. Res. 1987; 11: 104–44
   Web of Science ®Google Scholar
• Ohno R., Yoshida H., Fukutani H., Naoe T., Ohshima T., Kyo T., Endoh N., Fujimoto T., Kobayashi T., Hir-Aoka A., Mizoguchi H., Kodera Y., Suzuki H., Hirano M., Akiyama H., Aoki N., Shindo H., Yokomaku S., The Leukemia Study Group of the Ministry of Health and Welfare. Multiinstitutional study of all-trans retinoic acid as a differentiation therapy of acute promyelocytic leukemia. Leukemia 1993; 7: 1722–27
   PubMed Web of Science ®Google Scholar
• Rowley J. D. Molecular cytogenetics: Rosetta stone for understanding cancer. Cancer Res. 1990; 50: 3816–25
   PubMed Web of Science ®Google Scholar
• de The H., Chomienne C., Lanotte M., Degos L., De-Jean A. The t(15; 17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor-a gene to a novel transcribed locus. Nature 1990; 347: 558–61
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Umesono K., Warrell R. P., Frankel S. R., Murty V. V. V.S., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML. Cell 1991; 66: 663–74
   PubMed Web of Science ®Google Scholar
• de The H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RARa fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–84
   PubMed Web of Science ®Google Scholar
• Nowell P. C. Chromosome abnormalities in myelo-blastic syndromes. Semin. Oncol. 1992; 19: 25–33
   PubMed Web of Science ®Google Scholar
• Gallagher R. E., Lurie K. J., Leavitt R. D., Wiernik P. H. Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-aA interferon. Leuk. Res. 1987; 11: 609–19
   PubMed Web of Science ®Google Scholar
• Santini V., Colombat P. H., Delwel R., Gurp R. V., Touw I., Lowenberg B. Induction of granulocytic maturation in acute myeloid leukemia by G-CSF and retinoic acid. Leuk. Res. 1991; IS: 341–50
   Web of Science ®Google Scholar
• Yoshida Y., Hirashima K., Asano S., Takaku F. A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br. J. Haematol. 1991; 78: 378–84
   PubMed Web of Science ®Google Scholar